Top Stories

• 

  Judge Seems To Favor Susman Godfrey In Trump Challenge

  By Jared Foretek

  A D.C. federal judge appeared poised Thursday to allow Susman Godfrey LLP's challenge to President Donald Trump'...(read more)

• 

  Pa. Panel Backs $175M Roundup Verdict Against Monsanto

  By P.J. D'Annunzio

  Bayer AG unit Monsanto has failed to erase a $175 million verdict awarded to a man who alleged his cancer was ca...(read more)

ADVERTISEMENT


• J&J Unit's Encryption Tech Stalled Rival, Antitrust Jury Told

  By Gina Kim

  An Innovative Health executive told California federal jurors considering its antitrust claims Thursday that Johnson & Johnson unit Biosense Webster added encryption technology to its catheters to prevent reuse, hindering Innovative's ability to reprocess the catheters and delaying its entry into the market for years. 

• DC Circ. To Decide If Zero Is Less Than 40 In DCA Slot Fight

  By Nadia Dreid

  The D.C. Circuit wasn't convinced by the U.S. Department of Transportation's arguments Thursday morning as it worked to convince the panel that the agency hadn't wrongfully excluded Frontier Airlines from new slot exemptions at one of Washington, D.C.'s main airports.

• Ramey IP Atty Likely To Get Sanctioned Over Netflix Doc Swap

  By Dorothy Atkins

  A California federal judge indicated Thursday he'll likely grant Netflix's request for monetary sanctions against a prolific patent plaintiff's former counsel William Ramey and the Ramey LLP law firm for giving Netflix's confidential information to nonparty AiPi LLC, but probably won't pursue the streamer's request for a civil contempt finding.

• Instagram Head Says App 'Blends' Friends And Entertainment

  By Bryan Koenig

  The head of Instagram didn't shy away Thursday from Federal Trade Commission arguments about how Meta functions as a social media platform, testifying in D.C. federal court that sharing with friends and family is a key function, but part of a blended approach also focused on entertainment.

• Oppenheimer Slips Suits Over Fraudster's $110M Ponzi Scheme

  By Chart Riggall

  A cohort of investors who said they were victims of a $110 million Ponzi scheme run by a former Oppenheimer & Co. Inc. adviser can't hold the investment firm liable for their losses, the Georgia Court of Appeals has said, ruling their losses were "at best, an indirect result" of the firm's alleged efforts to cover up the scheme.

• Fed. Circ. Questions Roku Bid To Undo ITC Patent Loss

  By Ryan Davis

  Roku's effort to revive its U.S. International Trade Commission remote control patent case against Universal Electronics and others drew skepticism from the Federal Circuit on Thursday, with the judges questioning Roku's claim the patent was wrongly found invalid and that the company has a domestic industry.

• No 'Clean Slate' For Samsung After Epic's Win Against Google

  By Bonnie Eslinger

  A California federal judge overseeing Epic Games' lawsuit alleging Samsung and Google colluded to dodge an injunction related to Google's Play Store warned the parties on Thursday that he won't completely ignore jury findings in a similar case that Epic won against Google, noting that "we're not writing on a clean slate."

• Fed. Circ. Weighs If Expert's Testimony Justifies Spine IP Loss

  By Theresa Schliep

  A Federal Circuit panel on Thursday considered how much an expert strayed from a lower court's claim construction in an inventor's patent infringement suit against DePuy Synthes, with one judge questioning if it was merely effective cross-examination that tripped the expert up, and not much more.

• Google Payment Unit Ends Suit As CFPB Nixes Oversight Plan

  By Sarah Jarvis

  Google Payment Corp. disclosed Thursday that the Consumer Financial Protection Bureau has agreed to drop Biden-era plans to supervise the tech giant's payment arm, leading the company to drop its suit against the regulator.

• Hikma Cuts $50M Deal To End Antitrust Claims In Xyrem MDL

  By Dorothy Atkins

  A certified class of Xyrem buyers in 36 states have asked a California federal judge to preliminarily approve Hikma Pharmaceuticals PLC's $50 million deal to resolve antitrust claims accusing Hikma of colluding with rival Jazz Pharmaceuticals to block generic rivals from competing with Jazz's narcolepsy drug.

• 3rd Circ. Rejects Challenge To Medicare Drug Price Program

  By George Woolston

  The Third Circuit on Thursday rejected AstraZeneca's challenge to the Medicare drug price negotiation program, ruling that the pharmaceutical giant was unable to show how it is injured by the program's guidance or how it violates its due process rights.

• Judge Asks DOJ To Define DEI In Health Grant Case

  By Julie Manganis

  A Massachusetts federal judge on Thursday ordered U.S. Department of Justice lawyers to provide the Trump administration's definitions of diversity, equity and inclusion, saying he needs to know so he can consider whether that is a valid basis for pausing federal health research grants.